Factors associated with improved survival among older colorectal cancer patients in the US: a population-based analysis
Open Access
- 13 July 2009
- journal article
- Published by Springer Nature in BMC Cancer
- Vol. 9 (1) , 227
- https://doi.org/10.1186/1471-2407-9-227
Abstract
Background: The purpose of this study was to estimate the relative impact of changes in demographics, stage at detection, treatment mix, and medical technology on 5-year survival among older colorectal cancer (CRC) patients. Methods: We selected older patients diagnosed with CRC between 1992 and 2000 from the SEER-Medicare database and followed them through 2005. Trends in demographic characteristics, stage at detection and initial treatment mix were evaluated descriptively. Separate multivariate logistic regression models for colon (CC) and rectal cancer (RC) patients were estimated to isolate the independent effects of these factors along with technological change (proxied by cohort year) on 5-year survival. Results: Our sample included 37,808 CC and 13,619 RC patients (combined mean ± SD age: 77.2 ± 7.0 years; 55% female; 87% white). In recent years, more CC patients were diagnosed at Stage I and fewer at Stages II and IV, and more RC patients were diagnosed at Stage I and fewer at Stages II and III. CC and RC patients diagnosed in later years were slightly older with somewhat better Charlson scores and were more likely to be female, from the Northeast, and from areas with higher average education levels. Surgery alone was more common in later years for CC patients while combined surgery, chemotherapy, and radiotherapy was more common for RC patients. Between 1992 and 2000, 5-year observed survival improved from 43.0% to 46.3% for CC patients and from 39.4% to 42.2% for RC patients. Multivariate logistic regressions indicate that patients diagnosed in 2000 had significantly greater odds of 5-year survival than those diagnosed in 1992 (OR: 1.35 for CC, 1.38 for RC). Our decomposition suggests that early detection had little impact on survival; rather, technological improvements (e.g., new medical technologies or more effective use of existing technologies) and changing demographics were responsible for the largest share of the change in 5-year survival in CC and RC between 1992 and 2000. Conclusion: Technological advances and changes in patient demographics had the largest impact on improved colorectal cancer survival during the study period.Keywords
This publication has 22 references indexed in Scilit:
- Lifetime and Treatment-Phase Costs Associated With Colorectal Cancer: Evidence from SEER-Medicare DataClinical Gastroenterology and Hepatology, 2009
- Cost of Care for Elderly Cancer Patients in the United StatesJNCI Journal of the National Cancer Institute, 2008
- Recent Major Progress in Long-Term Cancer Patient Survival Disclosed by Modeled Period AnalysisJournal of Clinical Oncology, 2007
- Cancer Survival Among US Whites and MinoritiesArchives of internal medicine (1960), 2002
- Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population.Published by Rockefeller University Press ,2002
- Estimating Health Care Costs Related to Cancer Treatment From SEER-Medicare DataMedical Care, 2002
- Are Deaths Within 1 Month of Cancer-Directed Surgery Attributed to Cancer?JNCI Journal of the National Cancer Institute, 2002
- Annual Report to the Nation on the status of cancer, 1973–1999, featuring implications of age and aging on U.S. cancer burdenCancer, 2002
- Medicare program; revisions to payment policies and five-year review of and adjustments to the relative value units under the physician fee schedule for calendar year 2002. Final rule with comment period.2001
- The potential and limitations of data from population-based state cancer registriesAmerican Journal of Public Health, 2000